The posters presented at NCDEU
support CRI Lifetree's ongoing commitment to provide innovative solutions in complex early phase trials," stated Larry Brownstein, CRI Lifetree Executive of Corporate Development.
focuses on timely issues in psychiatric clinical research and includes presentations and information from the American Society of Clinical Psychopharmacology (ASCP) and its federal partners, the National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism (NIAAA), the Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
conference is co-sponsored by the National Institute of Mental Health, the National Institutes of Health and the American Society for Clinical Psychopharmacology and brings together academic researchers from multiple disciplines involved in clinical trials, investigators with the pharmaceutical industry and representatives from government agencies, including the U.
The study being presented at NCDEU
suggests that it may be possible to identify patients who are at increased risk for adverse events during antidepressant treatment, and in particular which patients may experience worsening suicidal ideation.
OTC BB: IFMX) briefed key mental health experts on its Med-eMonitor(TM) web-based compliance-monitoring system during an executive session of industry thought leaders at the 44th Annual NCDEU
(New Clinical Drug Evaluation Unit) Meeting, held June 1-4 in Phoenix, AZ.